Almirall (LBTSF) News Today → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free LBTSF Stock Alerts $9.51 0.00 (0.00%) (As of 05/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAlmirall, S.A. reports FY resultsmsn.com - February 20 at 3:55 PMAlmirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology businessfinance.yahoo.com - February 19 at 8:21 AMAlmirall and Microsoft partner on AI-powered drug discovery in dermatologymsn.com - February 5 at 7:06 AMAlmirall, Etherna Team Up to Develop MRNA-Based Dermatology Therapiesmarketwatch.com - December 12 at 8:23 AMAlmirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical Dermatologyfinance.yahoo.com - December 12 at 3:22 AMAlmirall Shares Rise on European Approval for Skin Drugmarketwatch.com - November 17 at 2:43 PMAlmirall Receives European Commission Approval of EBGLYSS® (lebrikizumab) for Moderate-to-Severe Atopic Dermatitisfinance.yahoo.com - November 17 at 9:43 AMAlmirall and Absci partner on AI-driven dermatological drug developmentmsn.com - November 15 at 3:35 PMAbsci Corporation: Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseasesfinanznachrichten.de - November 14 at 8:21 AMAlmirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseasesfinance.yahoo.com - November 14 at 8:21 AMAbsci, Almirall partner on dermatologic drug developmentmsn.com - November 14 at 8:21 AMAlmirall, S.A. reports 9M resultsmsn.com - November 9 at 3:26 PMAlmirall’s Nine-month 2023 Results:businesswire.com - November 9 at 10:26 AMAlmirall's Lebrikizumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis (AD) in Patients Inadequately Controlled With or Ineligible for Cyclosporinebusinesswire.com - October 13 at 9:37 AMAlmirall and EpimAb partner to develop bispecific antibody therapiesmsn.com - October 12 at 10:48 PMEpimAb Biotherapeutics and Almirall Announce Bispecific Antibody License Agreementbusinesswire.com - October 12 at 7:47 AMAlmirall's Ilumetri® (tildrakizumab) Significantly Improves Wellbeing for Patients1 and Their Relatives2 in Moderate-to-Severe Plaque Psoriasisfinance.yahoo.com - October 11 at 10:09 AMCentrient Pharmaceuticals joins Almirall’s growing innovation hub in Barcelonabusinesswire.com - October 10 at 8:41 AMEMA’s CHMP supports Almirall’s Ebyglyss for atopic dermatitismsn.com - September 18 at 2:24 PMAlmirall, S.A. reports 1H resultsmsn.com - July 24 at 4:07 PMAlmirall: Ilumetri® (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasisfinance.yahoo.com - July 7 at 11:43 AMAlmirall announces the pricing and closing of its €200mm non pre-emptive share capital increasefinance.yahoo.com - June 13 at 6:13 PMAlmirall's Q1 core earnings beat estimates on Europe dermatology operationsnews.yahoo.com - May 8 at 11:13 AMAlmirall's core earnings beat estimates in Q1reuters.com - May 8 at 11:13 AMAlmirall’s First Quarter 2023 Resultsfinance.yahoo.com - May 8 at 11:13 AMAlmirall: Up to 73% of Atopic Dermatitis Patients Taking Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysisfinance.yahoo.com - May 1 at 7:51 AMCREDIT SUISSE - EUROPE Maintains Almirall (XMAD:ALM) Neutral Recommendationmsn.com - April 21 at 6:54 PMAlmirall, S.A. (ALM.MC)finance.yahoo.com - April 13 at 4:03 AMAlmirall, The First to Assess Wellbeing in a Dermatology Clinical Studyfinance.yahoo.com - April 12 at 8:01 AMAlmirall Shares Rise on Swing to 2022 Net Profit, CEO Confirmationmarketwatch.com - February 20 at 7:34 AMSpain's Almirall expects core earnings to fall in 2023reuters.com - February 20 at 7:34 AMAlmirall to Participate in the 41st Annual J.P. Morgan Healthcare Conferencenz.finance.yahoo.com - January 4 at 8:53 AMSpain's Almirall Q3 core earnings fall 13%; keeps outlookmsn.com - November 10 at 12:54 PMWeek In Review: YishengBio To List On Nasdaq Via SPAC Merger At An $834 Million Valueseekingalpha.com - October 3 at 1:40 AMSimcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fcbenzinga.com - September 29 at 12:02 AMAlmirall's Klisyri® (tirbanibulin) receives strong recommendation in American Academy of Dermatology AK guideline updatefinance.yahoo.com - August 18 at 10:00 AMAlmirall, S.A. 2022 Q2 - Results - Earnings Call Presentationseekingalpha.com - July 26 at 10:58 PMAlmirall, S.A. (LBTSF) CEO Gianfranco Nazzi on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - July 25 at 1:21 PMSpain's Almirall returns to profitability in first half as sales growmsn.com - July 25 at 8:21 AMHappify Health and Almirall Go Live with Digital Solution to Support Psoriasis Patientsfinance.yahoo.com - June 13 at 11:31 AMAlmirall, S.A.: Almirall: Eight out of Ten Patients Maintained Skin Clearance at One Year in Lebrikizumab Atopic Dermatitis Monotherapy Trialsfinanznachrichten.de - June 7 at 12:10 AMAlmirall: Eight out of Ten Patients Maintained Skin Clearance at One Year in Lebrikizumab Atopic Dermatitis Monotherapy Trialsfinance.yahoo.com - June 7 at 12:10 AMEvotec, Almirall team up to discover therapies for skin diseasesseekingalpha.com - May 19 at 4:04 PMEvotec AG: Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatologyfinanznachrichten.de - May 19 at 4:40 AMDGAP-News: Evotec and Almirall enter into a multi-target alliance in medical dermatologymarkets.businessinsider.com - May 19 at 4:40 AMEvotec Announces Collaboration With Almirallnasdaq.com - May 19 at 4:40 AMAlmirall, S.A. (LBTSF) CEO Gianfranco Nazzi on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 9 at 11:42 PMSpain's Almirall confirms 2022 target after first quarter profit dropnasdaq.com - May 9 at 8:41 AMAlmirall, S.A. reports Q1 resultsseekingalpha.com - May 9 at 8:41 AMHere's what Wall Street expects from Almirall's earningsmarkets.businessinsider.com - May 8 at 9:55 AM Get Almirall News Delivered to You Automatically Sign up to receive the latest news and ratings for LBTSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. LBTSF Media Mentions By Week LBTSF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LBTSF News Sentiment▼0.000.40▲Average Medical News Sentiment LBTSF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LBTSF Articles This Week▼00▲LBTSF Articles Average Week Get Almirall News Delivered to You Automatically Sign up to receive the latest news and ratings for LBTSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGIFF News FFNTF News ABSCF News ACRHF News ACRDF News ALEAF News AZFL News ERBB News AVTBF News AVCNF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:LBTSF) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Almirall, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
